• Aberrant Astrocytes May Lead to Parkinson’s, Other Neurodegerative Diseases
  • MYOLYN Seeks FDA Patent for Its MyoCycle Muscle-therapy Bikes
  • Natural Substance Squalamine Shows Promise as Treatment for Parkinson’s
  • EU Calls for Multinational Research Projects in Neurodegenerative Diseases
  • Visual and Touch Stimuli Can Trigger Release of Dopamine Lacking in Parkinson’s
  • Genervon Shares List of Genes Linked Parkinson’s, Working on Therapy Targeting Them
  • Early-onset Parkinson’s Patients May Benefit from More Niacin in Diet
  • Newly Created Molecules May Eventually Protect Cells from Diseases like Parkinson’s
  • Improvements in Deep Brain Stimulation Patterns May Lower Surgeries and Better Treat Patients
  • FDA Reviewing Request to Approve ADS-5102 to Treat Levodopa-induced Dyskinesia
  • Parkinson’s Treatment in EU, Ongentys, Seen to Reduce Off-Time in Levodopa Users
  • Boston University Neurologist Awarded $100,000 to Study Gene Linked to Parkinson’s